Cluster 252: recurrent disease metastatic patients progressive cancer refractory treatment received persistent 
Cluster 436: stratum dipg patients criteria inclusion progressed progressive recurrent non eligible 
Cluster 686: receive cytotoxic regimen persistent management allowed recurrent required additional disease 
Cluster 1814: regimens chemotherapy prior number received disease patients metastatic treatment progressive 
